AVEO Oncology
AVEO
#7317
Rank
โ‚ฌ0.45 B
Marketcap
13,09ย โ‚ฌ
Share price
0.00%
Change (1 day)
172.07%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -โ‚ฌ26.9 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are โ‚ฌ94.31 Million. In 2021 the company made an earning of -โ‚ฌ46.56 Million a decrease over its 2020 earnings that were of -โ‚ฌ31.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -โ‚ฌ26.9 Million-42.23%
2021 -โ‚ฌ46.56 Million49.9%
2020 -โ‚ฌ31.06 Million-479.04%
2019 โ‚ฌ8.19 M-276.17%
2018 -โ‚ฌ4.66 Million-91.79%
2017 -โ‚ฌ56.67 Million142.38%
2016 -โ‚ฌ23.38 Million78.51%
2015 -โ‚ฌ13.1 Million-71.55%
2014 -โ‚ฌ46.04 Million-50.72%
2013 -โ‚ฌ93.42 Million-4.88%
2012 -โ‚ฌ98.21 Million-426.29%
2011 โ‚ฌ30.09 M-159.85%
2010 -โ‚ฌ50.3 Million35.33%
2009 -โ‚ฌ37.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
โ‚ฌ27.16 B-107,283.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.93 B-31,392.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ1.41 B-5,689.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ4.50 B-17,858.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.37 B-33,148.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-โ‚ฌ1.98 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA